Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.
2.

WCA recommendations for the long-term treatment of generalized anxiety disorder.

Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety..

CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61. Review.

PMID:
14767398
3.

Treatment of generalized anxiety disorder.

Gorman JM.

J Clin Psychiatry. 2002;63 Suppl 8:17-23. Review.

4.

Generalized anxiety disorder: raising the expectations of treatment.

Allgulander C, Sheehan DV.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:68-78. Review.

PMID:
17450651
5.

Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

Bereza BG, Machado M, Einarson TR.

Clin Ther. 2009 Jun;31(6):1279-308. doi: 10.1016/j.clinthera.2009.06.004. Review.

PMID:
19695395
6.

Pharmacotherapy of generalized anxiety disorder.

Rickels K, Rynn M.

J Clin Psychiatry. 2002;63 Suppl 14:9-16. Review.

7.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

8.

Azapirones for generalized anxiety disorder.

Chessick CA, Allen MH, Thase M, Batista Miralha da Cunha AB, Kapczinski FF, de Lima MS, dos Santos Souza JJ.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006115. Review.

PMID:
16856115
9.

[Treatment of generalized anxiety: new pharmacologic approaches].

Boulenger JP.

Encephale. 1995 Nov-Dec;21(6):459-66. Review. French.

PMID:
8674471
10.

Pharmacotherapy of generalized anxiety disorder.

Davidson JR.

J Clin Psychiatry. 2001;62 Suppl 11:46-50; discussion 51-2. Review.

11.

Accident- and injury-related health-care utilization among benzodiazepine users and nonusers.

Oster G, Russell MW, Huse DM, Adams SF, Imbimbo J.

J Clin Psychiatry. 1987 Dec;48 Suppl:17-21. Review.

PMID:
2891685
12.

The clinical course and long-term management of generalized anxiety disorder.

Rickels K, Schweizer E.

J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):101S-110S. Review.

PMID:
1973934
13.
14.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
15.

Generalised anxiety disorder: treatment options.

Sramek JJ, Zarotsky V, Cutler NR.

Drugs. 2002;62(11):1635-48. Review.

PMID:
12109925
16.

Treating generalized anxiety disorder.

Gorman JM.

J Clin Psychiatry. 2003;64 Suppl 2:24-9. Review.

17.

Long-term treatment strategies in anxiety disorders.

Allgulander C, Hirschfeld RM, Nutt DJ.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:79-92. Review.

PMID:
12490824
18.

Selecting pharmacotherapy for generalized anxiety disorder.

Goodman WK.

J Clin Psychiatry. 2004;65 Suppl 13:8-13. Review.

19.

Hydroxyzine for generalised anxiety disorder.

Guaiana G, Barbui C, Cipriani A.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006815. doi: 10.1002/14651858.CD006815.pub2. Review.

PMID:
21154375
20.

Long term therapy of generalized anxiety disorder.

Rouillon F.

Eur Psychiatry. 2004 Apr;19(2):96-101. Review.

PMID:
15051109
Items per page

Supplemental Content

Support Center